259: Factors associated with fetal overgrowth in pregnancies affected by type 1 and type 2 pregestational diabetes mellitus

Autor:	Hayley M. Roylance, Karen B. Lesser, Kami M. Dixon, Kathryn L. Reed, Martin Feuerman
Rok vydání:	2012
Předmět:	Pediatrics medicine.medical_specialty Neonatal outcomes business.industry Health care Pregestational Diabetes medicine Obstetrics and Gynecology Fetal overgrowth business Treatment efficacy
Zdroj:	American Journal of Obstetrics and Gynecology. 206:S127
ISSN:	0002-9378
Popis:	QALY. RESULTS: Treating patients in Glucose Category 5 was the dominant strategy. Treatment was more expensive ($11,491.75 with treatment vs $10,734.42 without treatment) but more effective (56.914924 QALYs with treatment vs 56.897791 without treatment), with an incremental cost of $44203.00/QALY. In a one-way sensitivity of analysis of the degree of treatment efficacy, treatment remained cost-effective as long as it met 64% of its reported efficacy. CONCLUSION: Treating patients in Glucose Category 5 of the HAPO Trial is cost-effective in terms of improving maternal and neonatal outcomes. How the health care system will provide this expanded care to this group of women will need to be examined.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::91284b3d86c705598f4f08a54479407b https://doi.org/10.1016/j.ajog.2011.10.277 Zobrazit plný text záznamu Full Text from ScienceDirect